文献速递毛发、甲与色素性疾病

再生医学促进毛发健康:从原理到实践(第二部分)

Regenerative Medicine for Hair Health: From Principles to Practice (Part II).
PubMed 文献 · J Am Acad Dermatol · 2026-01-30

本文综述再生医学在毛发健康中的应用,聚焦WNT、BMP、SHH等信号通路对毛囊形成与周期的调控,并讨论间充质干细胞、富血小板血浆衍生物及细胞外囊泡等再生疗法在瘢痕性、非瘢痕性及自身免疫性脱发中的潜力。多数疗法仍处于实验阶段,受方案异质性、缺乏标准化表征及长期安全性与监管指导不足的限制,本文为教育性综述而非治疗推荐。

要点

  • WNT、BMP、SHH等通路调控毛囊形成与周期,是再生疗法的基础
  • 间充质干细胞、PRP衍生物、细胞外囊泡等再生疗法显示一定潜力
  • 多数再生疗法仍为实验性,方案异质且缺乏标准化表征

核心结论

  • 再生技术用于毛发再生尚处早期,多数为实验性且基于早期生物学认识。
  • 再生疗法在瘢痕性、非瘢痕性及自身免疫性脱发中显示潜力,但受方案异质性和缺乏标准化限制。

研究设计与样本

  • 本文为CME教育性综述,旨在定义术语、总结科学原理并突出当前研究方向。

主要发现

  • 发育生物学揭示WNT、BMP、SHH等信号通路调控毛囊隆起部和真皮乳头内的毛囊形成与周期。
  • 间充质干细胞、富血小板血浆衍生物及来源于骨髓、脂肪、脐带和血小板等的细胞外囊泡(外泌体)等再生方式正在研究中。
  • 这些疗法在瘢痕性、非瘢痕性及自身免疫性脱发中显示潜力,但受方案变异、缺乏标准化表征及长期安全性与监管指导需求限制。

临床怎么用

  • 临床医生应了解再生疗法的术语与科学原理,批判性评估新兴数据。
  • 未来整合再生疗法需兼顾科学、伦理与监管严谨性。

局限性

  • 多数再生疗法仍为实验性,基于早期生物学认识。
  • 方案存在变异性,缺乏标准化表征。
  • 长期安全性与监管指导尚待明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Regenerative technologies are increasingly being explored to support hair growth and follicular restoration, but most remain experimental and grounded in early-stage biological insights. Developmental biology has revealed key signaling pathways, such as WNT, BMP, and SHH, that regulate hair follicle formation and cycling within the bulge and dermal papilla. Building on these principles, a range of regenerative modalities are being studied, including mesenchymal stem cells (MSCs), platelet-rich plasma (PRP) derivatives, and extracellular vesicles (exosomes) derived from bone marrow, adipose tissue, umbilical cord, and platelets, among other sources. These therapies show potential across scarring, non-scarring, and autoimmune alopecia, yet remain limited by variability in protocols, lack of standardized characterization, and the need for long-term safety and regulatory guidance.. This CME article is intended as an educational overview rather than a therapeutic endorsement. Its primary goal is to define terminology, summarize scientific principles, and highlight current research directions to support clinician and trainee understanding. As regenerative therapies continue to evolve, closing the educational gap will help the dermatology community critically evaluate emerging data and responsibly integrate future advances with appropriate scientific, ethical, and regulatory rigor.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Wyles SP, Proffer SL, Pastore L, et al. Regenerative Medicine for Hair Health: From Principles to Practice (Part II). J Am Acad Dermatol. 2026. PMID: 41621669. doi:10.1016/j.jaad.2026.01.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。